Core Insights - Baxter International Inc. is a global healthcare company providing essential medical products, operating in a competitive landscape with peers like Medtronic and Becton Dickinson [1] - Morgan Stanley set a new price target for Baxter at $15, indicating a potential downside of approximately -21.38% from the current trading price of $19.08 [1][5] - Faruqi & Faruqi, LLP is investigating potential claims against Baxter for investors who purchased securities between February 23, 2022, and July 30, 2025 [2][4][5] Company Performance - Baxter's current stock price is $19.08, reflecting an increase of 1.81% or $0.34, with a trading volume of 8,389,032 shares [3][5] - The stock has fluctuated between a low of $18.55 and a high of $19.20 on the current trading day [3] - Over the past year, Baxter's stock reached a high of $37.74 and a low of $17.40 [3] - The company has a market capitalization of approximately $9.81 billion [3][5]